Euronext Paris Authorises the Listing of Oncodesign Precision Medicine (OPM) Shares on Euronext Access + in Connection With the Allocation of OPM Shares to Oncodesign Shareholders
28.09.2022 - Regulatory News: Oncodesign Precision Medicine (OPM), a subsidiary of Oncodesign (ALONC - FR0011766229) (Paris:ALONC), and Oncodesign announce that Euronext Paris S.A. has authorised on September 26, 2022 the admission to listing on Euronext Access ... Seite 1